AI
BCRX $20~$18~$16.50 loss of $0.27 per share, $0.02 better than the one analyst est of $(0.29). Co notes it currently has a cash/inv balance of $91.7 mn, or $3.40/sh. The co expects to begin recognizing revenue related to the Roche partnerships in 2006.
Know how to make God laugh?
Tell Her your plans ....
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
